RB, which owns Nurofen and Durex (among other brands), presented better-than-expected yearly results. Turnover remained pretty much level compared to last year, but its net profit managed decent growth.
Growth in 2016 as well
RB’s turnover reached nearly 8.9 billion pounds (11.5 billion euro) in 2015, about level compared to the year before, but much better than what analysts had expected at 8.81 billion pounds (11.4 billion euro). Former Reckitt Benckiser’s turnover growth reached 6 % if exchange rate fluctuations and acquisitions are ignored.
2015’s net profit grew 5% to 1.7 billion pounds (2.2 billion euro) and RB expects to continue this positive trend in 2016. There may be difficult market conditions this year, but the company still feels it can achieve a 4 to 5 % like-for-like turnover growth while its profit margin should also increase in 2016.
